Yan Cheng

9PUBLICATIONS
36CO-AUTHORS
Medical mycologyMedical infection agents (incl. prions)Medical biochemistry - proteins and peptides (incl. medical proteomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 09, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma.

Fumou Sun, Yan Cheng, Catherine Ma

|Mar 13, 2025
Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption.

Dongzheng Gai, Perry C Caviness, Oxana P Lazarenko

|Nov 06, 2024
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages.

Yan Cheng, Fumou Sun, Daisy V Alapat

|Mar 05, 2024
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.

Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng

|Jan 19, 2024
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.

Fumou Sun, Yan Cheng, Visanu Wanchai

Pageof 2